Re-resection Rates and Disease Recurrence in Crohn’s Disease: A Population-based Study Using Individual-level Patient Data
- 10 May 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 18 (10) , 1631-1643
Abstract
Despite advances in the medical treatment of Crohn’s disease [CD], many patients will still need bowel resections and face the subsequent risk of recurrence and re-resection. We describe contemporary re-resection rates and identify disease-modifying factors and risk factors for re-resection. We conducted a retrospective, population-based, individual patient-level data cohort study covering 47.4% of the Danish population, including all CD patients who underwent a primary resection between 2010 and 2020. Among 631 primary resected patients, 24.5% underwent a second resection, and 5.3% a third. Re-resection rates after 1, 5, and 10 years were 12.6%, 22.4%, and 32.2%, respectively. Reasons for additional resections were mainly disease activity [57%] and stoma reversal [40%]. Disease activity-driven re-resection rates after 1, 5, and 10 years were 3.6%, 10.1%, and 14.1%, respectively. Most stoma reversals occurred within 1 year [80%]. The median time to recurrence was 11.0 months. Biologics started within 1 year of the first resection revealed protective effect against re-resection for stenotic and penetrating phenotypes. Prophylactic biologic therapy at primary ileocaecal resection reduced disease recurrence and re-resection risk (hazard ratio [HR] 0.58, 95% confidence interval [CI] [0.34-0.99], p = 0.047). Risk factors for re-resection were location of resected bowel segments at the primary resection, disease location, disease behaviour, smoking, and perianal disease. Re-resection rates, categorised by disease activity, are lower than those reported in other studies and are closely associated with disease phenotype and localisation. Biologic therapy may be disease-modifying for certain subgroups when initiated within 1 year of resection.Keywords
This publication has 43 references indexed in Scilit:
- Disease course and treatment outcomes of Crohn's disease patients with early or late surgery – A Danish nationwide cohort study from 1997 to 2015Digestive and Liver Disease, 2022
- Contemporary Risk of Surgery in Patients With Ulcerative Colitis and Crohn’s Disease: A Meta-Analysis of Population-Based CohortsClinical Gastroenterology and Hepatology, 2021
- Rate of Reoperation Decreased Significantly After Year 2002 in Patients With Crohn's DiseaseClinical Gastroenterology and Hepatology, 2020
- Decreasing Risk of First and Subsequent Surgeries in Patients With Crohn's Disease in England From 1994 through 2013Clinical Gastroenterology and Hepatology, 2019
- Pathogenesis of fibrostenosing Crohn's diseaseTranslational Research, 2019
- Crohn's disease management after intestinal resection: a randomised trialThe Lancet, 2015
- Results of the 4th Scientific Workshop of the ECCO (Group II): Markers of intestinal fibrosis in inflammatory bowel diseaseJournal of Crohn's and Colitis, 2014
- Postoperative recurrent luminal Crohnʼs Disease: A systematic reviewInflammatory Bowel Diseases, 2012
- Management and prevention of postoperative Crohnʼs diseaseInflammatory Bowel Diseases, 2009
- Medical management of postoperative recurrence in Crohn's diseaseGastroenterology Clinics of North America, 2004